KOAN · Resonate Blends, Inc.
Market Cap
$58,575
Shares
195.25M
KOAN metrics
55 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.00
Market cap
$58,575
Price action
19 metricsPrice change (1W)
-40.0%
Price change (30D)
-40.0%
Price change (3M)
-72.7%
Price change (6M)
-81.3%
Price change (YTD)
-90.3%
Price change (1Y)
-93.3%
Trailing year
Price change (5Y)
-99.9%
52-week high
$0.02
52-week low
$0.00
Change from 52-week high
-98.5%
Change from 52-week low
+0.0%
Annualized volatility
214.0%
Beta
-0.4
RSI (14D)
36.4
Price vs SMA 50
-47.6%
Price vs SMA 200
-87.5%
Avg volume (3M)
5.34M
Relative volume
0.4
Average dollar volume
$3,307
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
195.25M
Valuation
12 metricsP / E (TTM)
0.0
Trailing earnings · reciprocal yield 6,666.7%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.0×
reciprocal yield 3,810.4%
P / book
—
FCF yield
-1,821.4%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
1,952.1%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
65.5%
Operating margin
-72.2%
Trailing 12 months
Net margin
51.2%
Gross profit (TTM)
$1.46M
Operating profit (TTM)
−$1.61M
Net income (TTM)
$1.14M
Trailing 12 months
Diluted EPS (TTM)
$0.02
FCF margin
-47.8%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+353.2%
Year over year
Net income growth YoY
—
Revenue (TTM)
$2.23M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+19.3%
Year over year · more shares
Revenue CAGR (3Y)
+312.4%
Revenue CAGR (5Y)
+12.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
95.1%
Debt / equity
—
Current ratio
0.2
EBITDA (TTM)
−$1.68M
Free cash flow (TTM)
−$1.07M
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$18,117
Total assets
$1.20M
Total debt
$187,619
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$1.07M
Capital expenditures (TTM)
$1,000
R&D (TTM)
—
SG&A (TTM)
$181,931
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Short interest
3 metricsShort interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
21 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—